Drug Shortage Report for CYTOVENE

Last updated on 2024-03-14 History
Report ID 184528
Drug Identification Number 02162695
Brand name CYTOVENE
Common or Proper name ganciclovir for injection
Company Name CHEPLAPHARM ARZNEIMITTEL GMBH
Market Status MARKETED
Active Ingredient(s) GANCICLOVIR
Strength(s) 500MG
Dosage form(s) POWDER FOR SOLUTION
Route of administration INTRAVENOUS INTRAVENOUS
Packaging size 500 mg/vial
ATC code J05AB
ATC description DIRECT ACTING ANTIVIRALS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2023-02-14
Estimated end date 2024-03-31
Actual end date 2024-03-13
Shortage status Resolved
Updated date 2024-03-14
Company comments
Health Canada comments
Tier 3 Status No
Contact Address ZIEGELHOF 24
GREIFSWALD, MECKLENBURG - WEST POMERANIA
GERMANY 17489
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v1 2023-02-14 English Compare
v2 2023-02-14 French Compare
v3 2023-02-15 English Compare
v4 2023-03-31 English Compare
v5 2023-03-31 French Compare
v6 2023-05-02 English Compare
v7 2023-05-02 French Compare
v8 2023-05-29 English Compare
v9 2023-05-29 French Compare
v10 2023-06-27 English Compare
v11 2023-06-27 French Compare
v12 2023-07-26 English Compare
v13 2023-07-26 French Compare
v14 2023-08-31 English Compare
v15 2023-08-31 French Compare
v16 2023-10-03 English Compare
v17 2023-10-03 French Compare
v18 2023-10-05 English Compare
v19 2023-10-05 French Compare
v20 2024-01-22 English Compare

Showing 1 to 20 of 26